ATE468535T1 - Verwendung von nnmt als marker für lungenkrebs - Google Patents

Verwendung von nnmt als marker für lungenkrebs

Info

Publication number
ATE468535T1
ATE468535T1 AT07801464T AT07801464T ATE468535T1 AT E468535 T1 ATE468535 T1 AT E468535T1 AT 07801464 T AT07801464 T AT 07801464T AT 07801464 T AT07801464 T AT 07801464T AT E468535 T1 ATE468535 T1 AT E468535T1
Authority
AT
Austria
Prior art keywords
lung cancer
nnmt
marker
assessment
relates
Prior art date
Application number
AT07801464T
Other languages
English (en)
Inventor
Wolfgang Rollinger
Marie-Luise Hagmann
Johann Karl
Theresa Kott
Markus Roessler
Michael Tacke
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE468535T1 publication Critical patent/ATE468535T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4742—Keratin; Cytokeratin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91005—Transferases (2.) transferring one-carbon groups (2.1)
    • G01N2333/91011—Methyltransferases (general) (2.1.1.)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • G01N2333/98—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT07801464T 2006-08-01 2007-07-30 Verwendung von nnmt als marker für lungenkrebs ATE468535T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06015951 2006-08-01
PCT/EP2007/006713 WO2008014951A1 (en) 2006-08-01 2007-07-30 Use of nnmt as a marker for lung cancer

Publications (1)

Publication Number Publication Date
ATE468535T1 true ATE468535T1 (de) 2010-06-15

Family

ID=37078767

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07801464T ATE468535T1 (de) 2006-08-01 2007-07-30 Verwendung von nnmt als marker für lungenkrebs

Country Status (9)

Country Link
US (1) US7785821B2 (de)
EP (1) EP2049905B1 (de)
JP (1) JP4981133B2 (de)
CN (1) CN101495870B (de)
AT (1) ATE468535T1 (de)
CA (1) CA2655851A1 (de)
DE (1) DE602007006671D1 (de)
ES (1) ES2345167T3 (de)
WO (1) WO2008014951A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010000467A1 (en) 2008-07-03 2010-01-07 F. Hoffmann-La Roche Ag Asc as a marker for lung cancer
WO2012123297A1 (en) * 2011-03-11 2012-09-20 Roche Diagnostics Gmbh Nnmt as marker for chronic obstructive pulmonary disease (copd)
CN103430027B (zh) * 2011-03-11 2015-05-20 霍夫曼-拉罗奇有限公司 Apex1作为慢性阻塞性肺病(copd)的标志物
CN102435748B (zh) * 2011-11-25 2014-07-16 广东药学院 一种双抗夹心酶联免疫检测试剂盒及其制备方法
CN102618501A (zh) * 2011-12-26 2012-08-01 浙江大学 Nnmt蛋白单克隆抗体、杂交瘤细胞株及应用
WO2014208156A1 (ja) * 2013-06-28 2014-12-31 栄研化学株式会社 新規肺癌マーカー（liph）
CN106248946A (zh) * 2016-08-19 2016-12-21 浙江大学 一种酶联免疫检测试剂盒及其应用
CN116762135A (zh) * 2021-01-14 2023-09-15 豪夫迈·罗氏有限公司 生物标志物在具有稳定疾病的非小细胞肺癌患者中的预后价值

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3691798B2 (ja) * 2002-02-18 2005-09-07 三洋化成工業株式会社 血液中の腫瘍マーカー定量方法
TW200413725A (en) * 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
US20060024692A1 (en) * 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
JP4248496B2 (ja) * 2002-12-20 2009-04-02 エフ．ホフマン−ラ ロシュ アーゲー 結腸直腸癌に対するマーカーとしてのニコチンアミドｎ−メチルトランスフェラーゼの使用
CN101088011B (zh) * 2004-12-23 2012-07-18 霍夫曼-拉罗奇有限公司 Cyfra21-1作为结肠直肠癌的标记的用途
JP5580205B2 (ja) * 2007-11-19 2014-08-27 セレラ コーポレーション 肺癌マーカーとその使用
EP2071337A1 (de) * 2007-12-10 2009-06-17 F.Hoffmann-La Roche Ag Seprase als Krebsmarker

Also Published As

Publication number Publication date
JP4981133B2 (ja) 2012-07-18
JP2009545731A (ja) 2009-12-24
DE602007006671D1 (de) 2010-07-01
US7785821B2 (en) 2010-08-31
WO2008014951A1 (en) 2008-02-07
CN101495870B (zh) 2013-09-04
CA2655851A1 (en) 2008-02-07
EP2049905B1 (de) 2010-05-19
ES2345167T3 (es) 2010-09-16
US20090263841A1 (en) 2009-10-22
CN101495870A (zh) 2009-07-29
HK1136873A1 (en) 2010-07-09
EP2049905A1 (de) 2009-04-22

Similar Documents

Publication Publication Date Title
ATE554389T1 (de) Apex als marker für lungenkrebs
ATE471512T1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
SG10201408392PA (en) Methods of determining patient response by measurement of her-3
ATE468535T1 (de) Verwendung von nnmt als marker für lungenkrebs
BRPI0814202A2 (pt) Métodos e sistemas de determinação de concentração de produto de análise em amostra fluida e meio legível em computador
MX2015016047A (es) Metodo y sistema para mantener o mejorar el bienestar.
DE60315715D1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
WO2010046443A3 (en) Methods for detection and diagnosis of a bone or cartilage disorder
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
DE602005014386D1 (de) Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome
EA201391627A1 (ru) Анализ на наличие лизилоксидазоподобных белков 2 и способы его применения
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
PE20120592A1 (es) Metodo con biomarcadores para el seguimiento de un tratamiento
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
DE602004001994D1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
ATE531822T1 (de) Diagnose von prostatakrebs
DE602007004570D1 (de) Verwendung von Nogo-C bei der Beurteilung von Herzversagen
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
ATE359516T1 (de) Verwendung des proteins crabp ii (cellular retinoic acid-binding protein ii) als marker für brustkrebs
WO2010130839A4 (en) Cybp as a marker of lung cancer
ATE529745T1 (de) Verfahren zur bewertung des hautempfindlichkeitsniveaus durch verwendung von mit plattenepithelkarzinom zusammenhängendem antigen als indikation
ATE393393T1 (de) Verwendung des proteins spee als marker für brustkrebs
DE602005014659D1 (de) Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebs
ATE418737T1 (de) Verwendung des proteins spermidinsynthase (spee) als marker für kolorektalkarzinom

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2049905

Country of ref document: EP